The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology that is used for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for COVID-19. Combining RNA and Antibody tests can significantly raise the sensitivity for detecting COVID-19 in infected individuals. This test has been authorized by the FDA under a EUA for professional use CLIA and CLIA WAIVED for Point Of Care. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. This product is intended for professional use and not for home use. FACT SHEET FOR HEALTHCARE PROVIDERS This test has been authorized by the FDA under a EUA for use by authorized CLIA laboratories. This device is CLIA waived for point of care use for fingerstick whole blood specimens only. The user should be trained in the procedure. Wear appropriate protective attire for your safety when handling patient samples. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. There should be a blue line in the control region (next to ) before testing, discard the device if there is no blue line.
The HY-T COVID-19 Antigen Self-Test (Nasal Swab) is lateral flow assay designed for the qualitative detection of specific SARS-CoV-2 antigen in human anterior nasal swab specimen. It is intended to be used for the detection of SARS-CoV-2 virus infection. The results obtained should not be the sole determinant for clinical decision. The HY-T COVID-19 Antigen Self-Test (Nasal Swab) is intended for use for home self-testing. Platform: Immunochromatographic Assay Format: Cassette Detection Specific: SARS-CoV-2 antigen Specimen: Nasal swab Sensitivity: * 97.17% Specificity: * 100% Assay Time: 15-20 minutes Shelf Life: 18 months * Vs FDA Emergency Use Authorized real-time RT-PCR Suitable for: Individuals who wish to know their status on COVID-19 infection (symptomatic and asymptomatic regardless of their vaccination status)Individuals who have had close contact with COVID-19 positive patientsIndividuals with suspected exposure to coronavirusIndividuals who show symptoms related to COVID-19 (fever, dry cough, tiredness, sore throat,headache etc)Employees to perform regular testing to avoid workplace transmission Other appropriate and necessary screenings (such as International Entrance, cross-state, pre-employment screening, pre-admission to higher learning institutions etc.
Covid-19 - Antigen - Schnelltests
nasal or throat swab, 25 tests per box, it has CE certificate
We can provide Covid-19 Rapid Antigen Test. Test with reliable results within minutes. Made in the USA. Lateral flow assay, No equipment required, Results within 10 minutes, minimally invasive specimen collection, nasal swab, POC (in patient care setting). Detects SARS-CoV2 nucleocapsid protein antigen with ultra high performance. Identifies acute infection with 88.4% sensitivity and 100% specificity. Complies with FDA. Principals or Buyer's Mandates only. No broker chains. FOB or CIF. Minimum order 500000 test please.
The COVID-19Antigen Rapid Test Cassette (Saliva) is a lateral flow immunoassay intended for the qualitative detection SARS-CoV-2 nucleocapsid antigens in saliva from individuals who are suspecte of COVID-19 by their healthcare provider. There are single pack and 25pcs products (SOFTEC COVID-19 Antigen Rapid Test (Saliva)25pcs Pack). The price of the product is determined by the number of orders.
SOFTEC COVID-19 Antigen Rapid Test (Nasal) The COVID-19 Antigen Rapid Test Cassette (Nasal Swab) is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV 2 nucleocapsid antigens in nasal swabs from individuals with suspected COVID-19 by health care providers. Results are for SARS-CoV-2 nucleocapsid antigen identification. The COVID 19 Antigen Rapid Test Cassette (Nasal Swab) is intended for use by medical professionals or trained operators experienced in performing lateral flow tests. The price of the product is determined by the number of orders.
Rapid Accurate Innovative Comfortable Lollipop style Integral This SARS-CoV-2 Antigen Kit (Saliva Pen) is a lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in saliva specimens from individuals who are suspected of COVID-19. The most suitable for over-the-counter (OTC) home use by laymen in a non-laboratory setting. The most widely used testing scenarios, like for school kids test. The most integral design, simple and easy use lollipop style. The fastest result deliver: result is available within only 15 minutes. Cat.No Description Package size CG123201 Goldsite SARS-CoV-2 Antigen Kit(Saliva Pen) 1T CG123207 Goldsite SARS-CoV-2Antigen Kit(Saliva Pen) 7T CG123225 Goldsite SARS-CoV-2Antigen Kit(Saliva Pen) 25T
Specimen Collection: Nasal, Saliva Packing: 1 test / 25 Tests Accurancy: >93% Specificy: 99% Warranty: 2 year Certificate: CE, ISO13485,BfArM,BASG,MDA,Thai FDA
Covid-19 Rapid Screening Emergency Response Test Accuracy 98% + CE & FDA Certificates Certified By Ministry Health Of Turkish Republic 15 MINUTES DETECTION TIME with one drop of finger stick blood *Exponentially faster *No queues, No result waiting times *Exponentially more cost effective *Early Detection & Elimination *Effortless and accessible to everyone worldwide instantly
IgG IgM Duo blood 5-10 min 93+% accuracy Made in South Korea
Rapid antigen test kit for detection of COVID-19 . Easy,safe and accurate
European CE Certified 15 Minutes Detection Time Format 25T/Kit Colloidal Gold Method Detection Substance: Antibody Type of Sample : Serum/Plasma/Whole Blood No instruments needed
Designed for qualitative detection of SARS-CoV-2 antibodies in human serum, plasma, and whole blood samples, novel coronavirus antibody detection reagent (Colloidal Gold Method) is regarded as auxiliary detection metrics towards on-site screening for suspected cases that have the negative results after nucleic acid testing. This rapid test can aid in the diagnosis of coronavirus infection and significantly shorten the detection time, yielding the results in 15 minutes.
Covid-19 Rapid Test kit(IgG/IgM) - Made in USA (Its made in USA product with Korean technology) - Product will be dispatched from USA. - Package : 25 Tests/Kit - Price : FOB USA(New Jersey), USD 13/test - MOQ : 100,000 test - Lead time : immediately (In stock) - USA FDA EUA approved - CE approved
GENEDIA W COVID-19 Ag (Saliva) GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request. To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away. 1. Nasopharyngeal 2. Nasal 3. Saliva
Antigen-COVID-19 Virus Test Kit (Colloidal gold) 25pcs/kit High quality Fast delivery CE certified
Covid 19 Rapid Antigen Test Kits
The PocRoc SARS-CoV-2 Antigen Rapid Test Kit (TRFIA) is an immunofluorescent sandwich assay. It can detect the virus with very high sensitivity and specificity. When the sample is applied to the sample wells, SARS-CoV N protein and labeled antibody complexes are formed and travel up the strip. The labeled microsphere fluorescent probe reagent is used to form a visible red line with a matched UV flashlight. The presence of SARS-CoV-2 will be indicated by a visible red test line (T) in the result window. The membrane is pre-coated with Chicken IgY on the control (C) line. Control (C) line appears in each result window when the sample has flowed through the strip.
The Pathocatch Coviself Covid - 19 Rapid Antigen test (RAT) is an in vitro diagnostic test for the qualitative detection of covid - 19 antigen in nasal swab specimens directly from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19.
